WuXi AppTec provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and beyond. Our platforms offer expertise in all major disease areas and target classes, across a broad range of therapeutic modalities.

Therapeutic modalities include:

ADC, antibody drug conjugate, payload, linker

Antibody Drug Conjugates (ADC)

CAR-T Cell (Chimeric Antigen Receptor)

oligo, oligonucleotide, siRNA, ASO, miRNA, RNA, DNA

Oligonucleotides

antiviral, virus particles, DNA, nucleic acid, infectious disease

Oncolytic Viruses

peptide, amino acid chain

Peptides

PROTAC, bifunctional molecules, E3 ligase, POI, molecular glue, Proteolysis-targeting chimera

Targeted Protein Degradation